Construction and Characterization of 1F5 Chimeric Anti-CD20 Monoclonal Antibodies: An Efficient Splicing by Overlap Extension-polymerase Chain Reaction Technique
Despite the unparalleled success of anti-CD20-targeted immunotherapy, the currently available mAbs are not sufficiently efficacious in the treatment of lymphoma. 1F5 is one of a panel of anti-CD20 mAbs that was used in the B-cell lymphoma serotherapy. Despite the efficacy of murine 1F5 mAbs in lymp...
Main Authors: | Fatemeh Khademi, Pantea Mohammadi, Ali Mostafaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2021-04-01
|
Series: | Iranian Journal of Allergy, Asthma and Immunology |
Subjects: | |
Online Access: | https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2746 |
Similar Items
-
Resistance of Cloned 1F5 Chimeric Anti-CD20 Antibody Heavy-Chain Gene to DNA Polymerase due to a Predicted Hairpin Structure
by: Fatemeh Khademi, et al.
Published: (2016-11-01) -
Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
by: Mahdi Fasihi-Ramandi, et al.
Published: (2015-10-01) -
Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
by: Pejčić Ivica, et al.
Published: (2009-01-01) -
Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
by: Singh SK, et al.
Published: (2018-11-01) -
Radiolabeling and biodistribution of monoclonal antibody (MAb) anti-CD20 with iodine-131
by: Akinkunmi Ganiyu Akanji, et al.
Published: (2005-10-01)